Line Nederby

Persistence of <i><scp>DNMT</scp>3A</i> mutations at long‐term remission in adult patients with <scp>AML</scp>

Gro Grunnet Pløen, Line Nederby, Per Guldberg et al. · British Journal of Haematology · 2014 · 118 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Pathology +18

h<scp>MICL</scp> and <scp>CD</scp>123 in combination with a <scp>CD</scp>45/<scp>CD</scp>34/<scp>CD</scp>117 backbone – a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia

Anne Stidsholt Roug, Hanne Østergård Larsen, Line Nederby et al. · British Journal of Haematology · 2013 · 51 citations · Full text

Mapping the <scp>CLEC</scp>12A expression on myeloid progenitors in normal bone marrow; implications for understanding <scp>CLEC</scp>12A‐related cancer stem cell biology

Marie Bill, Peter Buur van Kooten Niekerk, Petter Woll et al. · Journal of Cellular and Molecular Medicine · 2018 · 46 citations · Full text

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy

Jon Røikjær Henriksen, Line Nederby, Frede Donskov et al. · Journal of Ovarian Research · 2020 · 36 citations · Full text

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome

Marie Toft‐Petersen, Line Nederby, Eigil Kjeldsen et al. · British Journal of Haematology · 2016 · 33 citations · Full text